Filing Details

Accession Number:
0001209191-20-046962
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-17 16:38:17
Reporting Period:
2020-08-13
Accepted Time:
2020-08-17 16:38:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1660334 Verrica Pharmaceuticals Inc. VRCA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1184432 Brian A Davis C/O Verrica Pharmaceuticals Inc.
10 North High Street, Suite 200
West Chester PA 19380
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-08-13 7,900 $6.24 7,900 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.19 to$6.27 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities andExchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in thisfootnote.